학술논문

A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 24 April 2018, 2(8):825-831)
Subject
Language
English
ISSN
24739537
24739529